On September 9, Argan declined 5.05% in regular trading to $414.745 per share, with turnover of approximately $81.78 million. The stock had earlier rallied on strong Q2 results before reversing sharply during the session.

On the news front, Piper Sandler initiated coverage of Argan with an Underweight rating, forming a stark contrast with the prevailing bullish consensus. According to FactSet, Argan currently carries an average analyst rating of Overweight with a mean price target of $573. The bearish initiation acted as a contrarian shock amid elevated market optimism, prompting concentrated profit-taking among holders sitting on substantial cumulative gains.

For context, Argan reported fiscal Q2 adjusted EPS of $3.76, far exceeding the FactSet consensus estimate of $2.64 and representing a 50.4% year-over-year increase. Revenue came in at $384 million, up 61.5% from $237.7 million a year earlier, also significantly beating the $300.5 million analyst estimate. Despite the strong fundamental backdrop, the Underweight call intensified short-term pullback pressure on a stock that had already appreciated substantially.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)